Specialty Retail
Compare Stocks
4 / 10Stock Comparison
EYE vs DRVN vs NVST vs MNRO
Revenue, margins, valuation, and 5-year total return — side by side.
Auto - Dealerships
Medical - Equipment & Services
Auto - Parts
EYE vs DRVN vs NVST vs MNRO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Specialty Retail | Auto - Dealerships | Medical - Equipment & Services | Auto - Parts |
| Market Cap | $1.81B | $2.26B | $4.04B | $523M |
| Revenue (TTM) | $1.99B | $2.17B | $2.81B | $1.18B |
| Net Income (TTM) | $30M | $-198M | $68M | $-13M |
| Gross Margin | 56.5% | 52.1% | 55.1% | 34.8% |
| Operating Margin | 3.0% | -7.3% | 9.0% | 2.3% |
| Forward P/E | 32.6x | 10.9x | 17.2x | 32.4x |
| Total Debt | $695M | $4.00B | $1.71B | $529M |
| Cash & Equiv. | $39M | $170M | $1.21B | $21M |
EYE vs DRVN vs NVST vs MNRO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 21 | May 26 | Return |
|---|---|---|---|
| National Vision Hol… (EYE) | 100 | 49.2 | -50.8% |
| Driven Brands Holdi… (DRVN) | 100 | 48.9 | -51.1% |
| Envista Holdings Co… (NVST) | 100 | 68.3 | -31.7% |
| Monro, Inc. (MNRO) | 100 | 29.8 | -70.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EYE vs DRVN vs NVST vs MNRO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EYE carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 9.0%, EPS growth 202.8%, 3Y rev CAGR 6.5%
- 9.0% revenue growth vs MNRO's -6.4%
- +46.3% vs DRVN's -24.6%
- 1.5% ROA vs DRVN's -4.2%, ROIC 3.0% vs -2.2%
DRVN is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 2 yrs, beta 0.68
- Lower volatility, beta 0.68, current ratio 1.52x
- Beta 0.68, current ratio 1.52x
- Lower P/E (10.9x vs 17.2x)
NVST is the clearest fit if your priority is long-term compounding.
- -13.1% 10Y total return vs EYE's -18.0%
- 2.4% margin vs DRVN's -9.1%
MNRO is the clearest fit if your priority is dividends.
- 6.4% yield; 1-year raise streak; the other 3 pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.0% revenue growth vs MNRO's -6.4% | |
| Value | Lower P/E (10.9x vs 17.2x) | |
| Quality / Margins | 2.4% margin vs DRVN's -9.1% | |
| Stability / Safety | Beta 0.68 vs NVST's 1.65 | |
| Dividends | 6.4% yield; 1-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +46.3% vs DRVN's -24.6% | |
| Efficiency (ROA) | 1.5% ROA vs DRVN's -4.2%, ROIC 3.0% vs -2.2% |
EYE vs DRVN vs NVST vs MNRO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EYE vs DRVN vs NVST vs MNRO — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NVST leads in 2 of 6 categories
MNRO leads 1 • EYE leads 0 • DRVN leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NVST leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NVST is the larger business by revenue, generating $2.8B annually — 2.4x MNRO's $1.2B. NVST is the more profitable business, keeping 2.4% of every revenue dollar as net income compared to DRVN's -9.1%. On growth, EYE holds the edge at +15.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.0B | $2.2B | $2.8B | $1.2B |
| EBITDAEarnings before interest/tax | $153M | $17M | $342M | $90M |
| Net IncomeAfter-tax profit | $30M | -$198M | $68M | -$13M |
| Free Cash FlowCash after capex | $73M | $41M | $220M | $50M |
| Gross MarginGross profit ÷ Revenue | +56.5% | +52.1% | +55.1% | +34.8% |
| Operating MarginEBIT ÷ Revenue | +3.0% | -7.3% | +9.0% | +2.3% |
| Net MarginNet income ÷ Revenue | +1.5% | -9.1% | +2.4% | -1.1% |
| FCF MarginFCF ÷ Revenue | +3.7% | +1.9% | +7.8% | +4.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +15.1% | -9.5% | +14.4% | -4.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +111.3% | +5.1% | +130.0% | +150.0% |
Valuation Metrics
MNRO leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 61.7x trailing earnings, EYE trades at a 29% valuation discount to NVST's 86.7x P/E. On an enterprise value basis, MNRO's 9.4x EV/EBITDA is more attractive than DRVN's 126.4x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.8B | $2.3B | $4.0B | $523M |
| Enterprise ValueMkt cap + debt − cash | $2.5B | $6.1B | $4.5B | $1.0B |
| Trailing P/EPrice ÷ TTM EPS | 61.70x | -7.55x | 86.73x | -79.23x |
| Forward P/EPrice ÷ next-FY EPS est. | 32.60x | 10.90x | 17.21x | 32.40x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 58.08x | — |
| EV / EBITDAEnterprise value multiple | 16.20x | 126.43x | 13.28x | 9.41x |
| Price / SalesMarket cap ÷ Revenue | 0.91x | 0.97x | 1.49x | 0.44x |
| Price / BookPrice ÷ Book value/share | 2.12x | 3.63x | 1.32x | 0.84x |
| Price / FCFMarket cap ÷ FCF | 24.68x | — | 17.54x | 4.96x |
Profitability & Efficiency
NVST leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
EYE delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-28 for DRVN. NVST carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to DRVN's 6.58x. On the Piotroski fundamental quality scale (0–9), EYE scores 7/9 vs MNRO's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.5% | -28.4% | +2.2% | -2.1% |
| ROA (TTM)Return on assets | +1.5% | -4.2% | +1.2% | -0.8% |
| ROICReturn on invested capital | +3.0% | -2.2% | +4.8% | +2.5% |
| ROCEReturn on capital employed | +3.8% | -2.7% | +4.9% | +3.4% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.80x | 6.58x | 0.55x | 0.85x |
| Net DebtTotal debt minus cash | $656M | $3.8B | $496M | $509M |
| Cash & Equiv.Liquid assets | $39M | $170M | $1.2B | $21M |
| Total DebtShort + long-term debt | $695M | $4.0B | $1.7B | $529M |
| Interest CoverageEBIT ÷ Interest expense | 3.54x | -1.23x | 12.76x | 0.09x |
Total Returns (Dividends Reinvested)
Evenly matched — EYE and NVST each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NVST five years ago would be worth $5,340 today (with dividends reinvested), compared to $3,236 for MNRO. Over the past 12 months, EYE leads with a +46.3% total return vs DRVN's -24.6%. The 3-year compound annual growth rate (CAGR) favors EYE at 0.7% vs MNRO's -24.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -12.0% | -5.2% | +12.0% | -10.1% |
| 1-Year ReturnPast 12 months | +46.3% | -24.6% | +44.2% | +45.4% |
| 3-Year ReturnCumulative with dividends | +2.2% | -51.1% | -30.3% | -57.7% |
| 5-Year ReturnCumulative with dividends | -55.4% | -51.1% | -46.6% | -67.6% |
| 10-Year ReturnCumulative with dividends | -18.0% | -48.5% | -13.1% | -62.4% |
| CAGR (3Y)Annualised 3-year return | +0.7% | -21.2% | -11.3% | -24.9% |
Risk & Volatility
Evenly matched — DRVN and NVST each lead in 1 of 2 comparable metrics.
Risk & Volatility
DRVN is the less volatile stock with a 0.68 beta — it tends to amplify market swings less than NVST's 1.65 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVST currently trades 79.8% from its 52-week high vs DRVN's 69.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.62x | 0.68x | 1.65x | 1.50x |
| 52-Week HighHighest price in past year | $30.02 | $19.74 | $30.42 | $23.91 |
| 52-Week LowLowest price in past year | $14.38 | $9.80 | $16.33 | $12.20 |
| % of 52W HighCurrent price vs 52-week peak | +76.0% | +69.7% | +79.8% | +72.9% |
| RSI (14)Momentum oscillator 0–100 | 40.8 | 54.3 | 55.1 | 55.4 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 2.0M | 2.4M | 770K |
Analyst Outlook
Evenly matched — EYE and DRVN each lead in 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: EYE as "Buy", DRVN as "Buy", NVST as "Hold", MNRO as "Hold". Consensus price targets imply 129.5% upside for MNRO (target: $40) vs 11.2% for NVST (target: $27). MNRO is the only dividend payer here at 6.43% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $35.20 | $18.00 | $27.00 | $40.00 |
| # AnalystsCovering analysts | 14 | 15 | 19 | 24 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +6.4% |
| Dividend StreakConsecutive years of raises | 2 | 2 | — | 1 |
| Dividend / ShareAnnual DPS | — | — | — | $1.12 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | 0.0% | +4.1% | +0.1% |
NVST leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MNRO leads in 1 (Valuation Metrics). 3 tied.
EYE vs DRVN vs NVST vs MNRO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EYE or DRVN or NVST or MNRO a better buy right now?
For growth investors, National Vision Holdings, Inc.
(EYE) is the stronger pick with 9. 0% revenue growth year-over-year, versus -6. 4% for Monro, Inc. (MNRO). National Vision Holdings, Inc. (EYE) offers the better valuation at 61. 7x trailing P/E (32. 6x forward), making it the more compelling value choice. Analysts rate National Vision Holdings, Inc. (EYE) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EYE or DRVN or NVST or MNRO?
On trailing P/E, National Vision Holdings, Inc.
(EYE) is the cheapest at 61. 7x versus Envista Holdings Corp at 86. 7x. On forward P/E, Driven Brands Holdings Inc. is actually cheaper at 10. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — EYE or DRVN or NVST or MNRO?
Over the past 5 years, Envista Holdings Corp (NVST) delivered a total return of -46.
6%, compared to -67. 6% for Monro, Inc. (MNRO). Over 10 years, the gap is even starker: NVST returned -13. 1% versus MNRO's -62. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EYE or DRVN or NVST or MNRO?
By beta (market sensitivity over 5 years), Driven Brands Holdings Inc.
(DRVN) is the lower-risk stock at 0. 68β versus Envista Holdings Corp's 1. 65β — meaning NVST is approximately 141% more volatile than DRVN relative to the S&P 500. On balance sheet safety, Envista Holdings Corp (NVST) carries a lower debt/equity ratio of 55% versus 7% for Driven Brands Holdings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EYE or DRVN or NVST or MNRO?
By revenue growth (latest reported year), National Vision Holdings, Inc.
(EYE) is pulling ahead at 9. 0% versus -6. 4% for Monro, Inc. (MNRO). On earnings-per-share growth, the picture is similar: National Vision Holdings, Inc. grew EPS 202. 8% year-over-year, compared to -119. 3% for Monro, Inc.. Over a 3-year CAGR, DRVN leads at 16. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EYE or DRVN or NVST or MNRO?
Envista Holdings Corp (NVST) is the more profitable company, earning 1.
7% net margin versus -12. 5% for Driven Brands Holdings Inc. — meaning it keeps 1. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVST leads at 8. 3% versus -6. 0% for DRVN. At the gross margin level — before operating expenses — NVST leads at 55. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EYE or DRVN or NVST or MNRO more undervalued right now?
On forward earnings alone, Driven Brands Holdings Inc.
(DRVN) trades at 10. 9x forward P/E versus 32. 6x for National Vision Holdings, Inc. — 21. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MNRO: 129. 5% to $40. 00.
08Which pays a better dividend — EYE or DRVN or NVST or MNRO?
In this comparison, MNRO (6.
4% yield) pays a dividend. EYE, DRVN, NVST do not pay a meaningful dividend and should not be held primarily for income.
09Is EYE or DRVN or NVST or MNRO better for a retirement portfolio?
For long-horizon retirement investors, Driven Brands Holdings Inc.
(DRVN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 68)). Envista Holdings Corp (NVST) carries a higher beta of 1. 65 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DRVN: -48. 5%, NVST: -13. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EYE and DRVN and NVST and MNRO?
These companies operate in different sectors (EYE (Consumer Cyclical) and DRVN (Consumer Cyclical) and NVST (Healthcare) and MNRO (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: EYE is a small-cap quality compounder stock; DRVN is a small-cap quality compounder stock; NVST is a small-cap quality compounder stock; MNRO is a small-cap income-oriented stock. MNRO pays a dividend while EYE, DRVN, NVST do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.